Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01203540|
Recruitment Status : Completed
First Posted : September 16, 2010
Last Update Posted : January 31, 2012
Multicentre, Double blind, Randomized, Comparative Study(comparing N-acetyl-aspartyl-glutamic acid(NAAGA) in Abak preservative free device versus SALINE in Abak preservative free device.
Evaluation of the effects and safety of NAABAK® through inflammation markers and symptoms in patients with allergic conjunctivitis and dry eye syndrome after 3 months treatment.
The patients will attend 4 visits.
|Condition or disease||Intervention/treatment||Phase|
|Allergic Conjunctivitis||Drug: NAABAK eyedrops Drug: Saline eyedrops||Phase 4|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||21 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Evaluation of the Effect and Tolerance of Preservative Free NAAGA on the Inflammatory Component and Symptoms of Dry Eye Syndrome in Allergic Conjunctivitis Patients|
|Study Start Date :||October 2010|
|Actual Study Completion Date :||January 2011|
|Experimental: Naaga in ABAK system||
Drug: NAABAK eyedrops
|Placebo Comparator: Saline solution||
Drug: Saline eyedrops
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01203540
|Korea, Republic of|
|Seoul National University Bundang Hospital|
|Seongnam-si, Korea, Republic of|
|Seoul National University Boramae Medical Center|
|Seoul, Korea, Republic of|